ID

31218

Beschreibung

Efficacy Study of Avastin® With Pemetrexed +/- Carboplatin to Treat Elderly Patients With Non-small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00976456

Link

https://clinicaltrials.gov/show/NCT00976456

Stichworte

Versionen (1)
  1. 30.07.18 30.07.18 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

30. Juli 2018

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Non-squamous Non-small Cell Lung Cancer NCT00976456

Englisch

Eligibility Non-squamous Non-small Cell Lung Cancer NCT00976456

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
stage iiib and iv nsclc, excluded squamous cell nsclc
Beschreibung

Non-Small Cell Lung Carcinoma TNM clinical staging | Squamous Cell Non-Small Cell Lung Carcinoma Excluded

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0007131
UMLS CUI [1,2]
C3258246
UMLS CUI [2,1]
C0221910
UMLS CUI [2,2]
C0007131
UMLS CUI [2,3]
C0332196
age ≥ 65 years
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
ecog 0-2
Beschreibung

ECOG performance status

Datentyp

boolean

Alias
UMLS CUI [1]
C1520224
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
mixed, non-small cell and small cell tumours or mixed adenosquamous carcinomas with a predominant squamous component
Beschreibung

Non-small cell carcinoma Small Cell Carcinoma Mixed | Adenosquamous carcinoma Component Squamous Mixed

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1266002
UMLS CUI [1,2]
C0262584
UMLS CUI [1,3]
C0205430
UMLS CUI [2,1]
C0206623
UMLS CUI [2,2]
C1705248
UMLS CUI [2,3]
C1182670
UMLS CUI [2,4]
C0205430
history of haemoptysis
Beschreibung

Hemoptysis

Datentyp

boolean

Alias
UMLS CUI [1]
C0019079
evidence of tumour invading major blood vessels on imaging
Beschreibung

Tumor Invasion Blood Vessels Major Imaging

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1269955
UMLS CUI [1,2]
C0005847
UMLS CUI [1,3]
C0205164
UMLS CUI [1,4]
C0011923
radiotherapy within 28 days prior to enrolment
Beschreibung

Therapeutic radiology procedure

Datentyp

boolean

Alias
UMLS CUI [1]
C1522449
patients who are unable to interrupt aspirin or other nonsteroidal anti-inflammatory agents, other than an aspirin dose ≤ 1.3 grams per day, for a 5-day period (8-day period for long-acting agents, such as piroxicam)
Beschreibung

Unable to discontinue Aspirin | Unable to discontinue Non-Steroidal Anti-Inflammatory Agents | Exception Aspirin U/day Time Period | Exception Piroxicam Time Period

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1548265
UMLS CUI [1,2]
C0004057
UMLS CUI [2,1]
C1548265
UMLS CUI [2,2]
C0003211
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0004057
UMLS CUI [3,3]
C0456683
UMLS CUI [3,4]
C1948053
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C0031990
UMLS CUI [4,3]
C1948053
current or recent (within 10 days of first dose of bevacizumab) use of full-dose oral or parenteral anticoagulants or thrombolytic agent for therapeutic purposes. prophylactic use of anticoagulants is allowed
Beschreibung

Oral anticoagulants Dosage Full | Anticoagulants Parenteral | Fibrinolytic Agents | Anticoagulants Prophylactic allowed

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0354604
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0443225
UMLS CUI [2,1]
C0003280
UMLS CUI [2,2]
C1518896
UMLS CUI [3]
C0016018
UMLS CUI [4,1]
C0003280
UMLS CUI [4,2]
C0199176
UMLS CUI [4,3]
C0683607
clinically significant (i.e. active) cardiovascular disease for example cva (≤6 months before enrolment), myocardial infarction (≤6 months before enrolment), unstable angina, chf nyha class ≥ii, serious cardiac arrhythmia requiring medication during the study and might interfere with regularity of the study treatment, or not controlled by medication
Beschreibung

Cardiovascular Disease | Cerebrovascular accident | Myocardial Infarction | Angina, Unstable | Congestive heart failure New York Heart Association Classification | Cardiac Arrhythmia Serious Requirement Pharmaceutical Preparations | Cardiac Arrhythmia Serious Interferes with Study Protocol | Cardiac Arrhythmia Serious Uncontrolled

Datentyp

boolean

Alias
UMLS CUI [1]
C0007222
UMLS CUI [2]
C0038454
UMLS CUI [3]
C0027051
UMLS CUI [4]
C0002965
UMLS CUI [5,1]
C0018802
UMLS CUI [5,2]
C1275491
UMLS CUI [6,1]
C0003811
UMLS CUI [6,2]
C0205404
UMLS CUI [6,3]
C1514873
UMLS CUI [6,4]
C0013227
UMLS CUI [7,1]
C0003811
UMLS CUI [7,2]
C0205404
UMLS CUI [7,3]
C0521102
UMLS CUI [7,4]
C2348563
UMLS CUI [8,1]
C0003811
UMLS CUI [8,2]
C0205404
UMLS CUI [8,3]
C0205318
non-healing wound, active peptic ulcer or bone fracture
Beschreibung

Wound, non-healed | Peptic Ulcer | Fracture

Datentyp

boolean

Alias
UMLS CUI [1]
C0750433
UMLS CUI [2]
C0030920
UMLS CUI [3]
C0016658
history of abdominal fistula, gastrointestinal perforation or intra-abdominal abscess within 6 months of enrolment
Beschreibung

Abdominal fistula | Gastrointestinal perforation | Abdominal Abscess

Datentyp

boolean

Alias
UMLS CUI [1]
C1879311
UMLS CUI [2]
C0151664
UMLS CUI [3]
C0243001
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Non-squamous Non-small Cell Lung Cancer NCT00976456

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Non-Small Cell Lung Carcinoma TNM clinical staging | Squamous Cell Non-Small Cell Lung Carcinoma Excluded
Item
stage iiib and iv nsclc, excluded squamous cell nsclc
boolean
C0007131 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
C0221910 (UMLS CUI [2,1])
C0007131 (UMLS CUI [2,2])
C0332196 (UMLS CUI [2,3])
Age
Item
age ≥ 65 years
boolean
C0001779 (UMLS CUI [1])
ECOG performance status
Item
ecog 0-2
boolean
C1520224 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Non-small cell carcinoma Small Cell Carcinoma Mixed | Adenosquamous carcinoma Component Squamous Mixed
Item
mixed, non-small cell and small cell tumours or mixed adenosquamous carcinomas with a predominant squamous component
boolean
C1266002 (UMLS CUI [1,1])
C0262584 (UMLS CUI [1,2])
C0205430 (UMLS CUI [1,3])
C0206623 (UMLS CUI [2,1])
C1705248 (UMLS CUI [2,2])
C1182670 (UMLS CUI [2,3])
C0205430 (UMLS CUI [2,4])
Hemoptysis
Item
history of haemoptysis
boolean
C0019079 (UMLS CUI [1])
Tumor Invasion Blood Vessels Major Imaging
Item
evidence of tumour invading major blood vessels on imaging
boolean
C1269955 (UMLS CUI [1,1])
C0005847 (UMLS CUI [1,2])
C0205164 (UMLS CUI [1,3])
C0011923 (UMLS CUI [1,4])
Therapeutic radiology procedure
Item
radiotherapy within 28 days prior to enrolment
boolean
C1522449 (UMLS CUI [1])
Unable to discontinue Aspirin | Unable to discontinue Non-Steroidal Anti-Inflammatory Agents | Exception Aspirin U/day Time Period | Exception Piroxicam Time Period
Item
patients who are unable to interrupt aspirin or other nonsteroidal anti-inflammatory agents, other than an aspirin dose ≤ 1.3 grams per day, for a 5-day period (8-day period for long-acting agents, such as piroxicam)
boolean
C1548265 (UMLS CUI [1,1])
C0004057 (UMLS CUI [1,2])
C1548265 (UMLS CUI [2,1])
C0003211 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0004057 (UMLS CUI [3,2])
C0456683 (UMLS CUI [3,3])
C1948053 (UMLS CUI [3,4])
C1705847 (UMLS CUI [4,1])
C0031990 (UMLS CUI [4,2])
C1948053 (UMLS CUI [4,3])
Oral anticoagulants Dosage Full | Anticoagulants Parenteral | Fibrinolytic Agents | Anticoagulants Prophylactic allowed
Item
current or recent (within 10 days of first dose of bevacizumab) use of full-dose oral or parenteral anticoagulants or thrombolytic agent for therapeutic purposes. prophylactic use of anticoagulants is allowed
boolean
C0354604 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0443225 (UMLS CUI [1,3])
C0003280 (UMLS CUI [2,1])
C1518896 (UMLS CUI [2,2])
C0016018 (UMLS CUI [3])
C0003280 (UMLS CUI [4,1])
C0199176 (UMLS CUI [4,2])
C0683607 (UMLS CUI [4,3])
Cardiovascular Disease | Cerebrovascular accident | Myocardial Infarction | Angina, Unstable | Congestive heart failure New York Heart Association Classification | Cardiac Arrhythmia Serious Requirement Pharmaceutical Preparations | Cardiac Arrhythmia Serious Interferes with Study Protocol | Cardiac Arrhythmia Serious Uncontrolled
Item
clinically significant (i.e. active) cardiovascular disease for example cva (≤6 months before enrolment), myocardial infarction (≤6 months before enrolment), unstable angina, chf nyha class ≥ii, serious cardiac arrhythmia requiring medication during the study and might interfere with regularity of the study treatment, or not controlled by medication
boolean
C0007222 (UMLS CUI [1])
C0038454 (UMLS CUI [2])
C0027051 (UMLS CUI [3])
C0002965 (UMLS CUI [4])
C0018802 (UMLS CUI [5,1])
C1275491 (UMLS CUI [5,2])
C0003811 (UMLS CUI [6,1])
C0205404 (UMLS CUI [6,2])
C1514873 (UMLS CUI [6,3])
C0013227 (UMLS CUI [6,4])
C0003811 (UMLS CUI [7,1])
C0205404 (UMLS CUI [7,2])
C0521102 (UMLS CUI [7,3])
C2348563 (UMLS CUI [7,4])
C0003811 (UMLS CUI [8,1])
C0205404 (UMLS CUI [8,2])
C0205318 (UMLS CUI [8,3])
Wound, non-healed | Peptic Ulcer | Fracture
Item
non-healing wound, active peptic ulcer or bone fracture
boolean
C0750433 (UMLS CUI [1])
C0030920 (UMLS CUI [2])
C0016658 (UMLS CUI [3])
Abdominal fistula | Gastrointestinal perforation | Abdominal Abscess
Item
history of abdominal fistula, gastrointestinal perforation or intra-abdominal abscess within 6 months of enrolment
boolean
C1879311 (UMLS CUI [1])
C0151664 (UMLS CUI [2])
C0243001 (UMLS CUI [3])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video